Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00969111 · ClinicalTrials.gov registry record · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
A NA study of Prostate Cancer, sponsored by Proton Collaborative Group.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 4
- Study locations
NCT00969111: Recruiting NA study of Prostate Cancer, sponsored by Proton Collaborative Group.
NCT00969111 is a NA study of Prostate Cancer that is actively recruiting participants, run by Proton Collaborative Group. The registered enrollment target is 70 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00969111, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Proton Collaborative Group.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.
Conditions Studied
Interventions
- RADIATION IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE
- RADIATION Proton (prostate bed) to 70.2 CGE
- RADIATION IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE
- RADIATION Proton to 66.6 CGE
Study Locations (4)
Arkansas
- Proton Center of Arkansas - Little Rock
Florida
- University of Florida Proton Therapy Institute - Jacksonville
Illinois
- Northwestern Medicine Chicago Proton Center - Warrenville
Virginia
- Inova Schar Cancer Institute - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2009-08 |
| Est. Completion | 2050-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00969111
The ClinicalTrials.gov registry entry for NCT00969111 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower). The listed sponsor is Proton Collaborative Group, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE is the first listed.
NCT00969111 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arkansas, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT00969111 about?
NCT00969111 is a clinical study titled "Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy". The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.
What is the current status of trial NCT00969111?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2009-08. Estimated completion is 2050-08.
What conditions does trial NCT00969111 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00969111?
The interventions under investigation include: IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE (RADIATION), Proton (prostate bed) to 70.2 CGE (RADIATION), IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE (RADIATION), Proton to 66.6 CGE (RADIATION).
Who is sponsoring clinical trial NCT00969111?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00969111 being conducted?
This trial has 4 study locations across Arkansas, Florida, Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.